Chronic opioid use: A risk factor for central sleep apnoea and successful therapy with adaptive pressure support servo-ventilation

7Citations
Citations of this article
40Readers
Mendeley users who have this article in their library.

Abstract

Sleep apnoea is a global health problem with significant morbidity. Obesity is a well-known risk factor for this condition, however chronic intake of opioids as a risk factor for central sleep apnoea is under-recognised. We report a case of a 47-year-old man who developed significant sleep-disordered breathing secondary to opioid use for chronic pain. A sleep study demonstrated a picture of complex sleep apnoea with a prominent central sleep apnoea component. He had no significant improvement with conventional continuous positive airway pressure therapy. However, adaptive servo-ventilation had a dramatic effect on his symptoms and compliance. This case highlights the significant risk of central sleep apnoea with opioid use and illustrates the importance of adaptive servo-ventilation in the management of sleep-disordered breathing secondary to impaired central respiratory drive. © 2012 Royal College of Physicians of Edinburgh.

Cite

CITATION STYLE

APA

Fahim, A., & Johnson, A. O. (2013). Chronic opioid use: A risk factor for central sleep apnoea and successful therapy with adaptive pressure support servo-ventilation. Journal of the Royal College of Physicians of Edinburgh, 42(4), 314–316. https://doi.org/10.4997/JRCPE.2012.407

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free